AI assistant
Sending…
RIGEL PHARMACEUTICALS INC — Director's Dealing 2010
May 29, 2010
32801_dirs_2010-05-28_ed8b2cac-4dec-467d-a9de-f762fc781453.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RIGEL PHARMACEUTICALS INC (RIGL)
CIK: 0001034842
Period of Report: 2010-05-28
Reporting Person: RINGROSE PETER S (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-05-28 | Stock Option (Right to Buy) | $6.73 | A | 15000 | Acquired | 2020-05-28 | Common Stock (15000) | Direct |
Footnotes
F1: The shares vest monthly for twelve (12) months from the date of grant.
More from RIGEL PHARMACEUTICALS INC
Regulatory Filings
2026
May 20
Proxy Solicitation & Information Statement
2026
Apr 3
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 3
Annual Report
2026
Mar 3
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19
Director's Dealing
2026
Feb 19